Multifocal motor neuropathy improved by IVIg: Randomized double-blind, placebo-controlled study

Neurology

Volumn 55, Issue 9, 2000, Pages 1256-1262

  Federico, P ^a   Zochodne, D W ^a   Hahn, A F ^b   Brown, W F ^c   Feasby, Thomas E ^a,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c TUFTS MEDICAL CENTER   (United States)

^d FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FUNCTIONAL ASSESSMENT; HUMAN; MOTOR NEUROPATHY; MUSCLE STRENGTH; NEUROLOGIC EXAMINATION; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 0034649381     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.9.1256     Document Type: Article

References (30)

1. Multifocal motor neuropathy
2. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies
3. A syndrome of asymmetric limb weakness with motor conduction block
4. Multifocal motor neuropathy with conduction block: Is it a distinct clinical entity?
5. Multifocal demyelinating motor neuropathy: Cranial nerve involvement and immunoglobulin therapy
6. Pathological findings at the site of conduction block in multifocal motor neuropathy
7. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular disease: A study of 180 sera
8. The clinical and diagnostic role of anti-GM1 ganglioside testing
9. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy - A double-blind, sham-controlled, cross-over study
10. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
11. Immunosuppressive treatment in multifocal motor neuropathy
12. Motor neuropathy with multifocal conduction blocks
13. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease
14. Chronic motor neuropathies: Response to interferon-β1a after failure of conventional therapies
15. Multifocal motor neuropathy: Response to human immune globulin
16. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: A double-blind, placebo-controlled study
17. Multifocal motor neuropathy with conduction block: A study of 24 patients
18. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: A double blind, placebo controlled study
19. Pure motor demyelinating neuropathy: Deterioration after steroid treatment and improvement with intravenous immunoglobulin
20. Intravenous immunoglobulin for multifocal motor neuropathy
21. Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy
22. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment
23. The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy
24. Internodal conduction in undissected demyelinated nerve fibers
25. Use of human intravenous immunoglobulin in lower motor neuron syndromes
26. Long term follow up of multifocal motor neuropathy with conduction block under treatment
27. Improvement of multifocal motor neuropathy during long-term weekly treatment with human immunoglobulin
28. The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy
29. Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy
30. Antiserum-mediated demyelination: Relationship between remyelination and functional recovery